抗PD1抗體及其作為治療劑與診斷劑的用途

• 收藏
• 分享

专利权人:

BeiGene Ltd.

发明人:

SONG, Jing,LI, Kang,ZHANG, Tong,XU, Lanlan,LIU, Qi,PENG, Hao,宋兢,李康,張彤,徐蘭蘭,劉琦,彭浩

申请号：

HK16105444.3

公开号：

HK1217501A

申请日:

2016.05.12

申请国别(地区):

HK

年份:

2017

代理人:

摘要：

Provided are antibodies that specifically bind to Programmed Death-1 (PD1, Pdcd-1, or CD279) and inhibit PD1-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PD1-mediated functions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/